Skip to main content

Table 1 Outcome assessment

From: A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial

Visit

Lead-in

Double-blind trial

Timescale

M-3

W-6

M0

M3

M6

M9

M12

M15

M18

ALSFRS-R

ALSAQ-40 questionnaire

FVC

EQ-5D-5L questionnaire

MRC sum-score

Survival or respiratory insufficiency

Blood biomarkers

  

 

 

 

CSF biomarkers

  

   

  

Safety parameters

  1. M month, W week